Literature DB >> 10502465

Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.

M Shiseki1, K Miwa, Y Nemoto, H Kato, J Suzuki, K Sekiya, T Murai, T Kikuchi, N Yamashita, K Totsuka, K Ooe, Y Shimizu, T Uchiyama.   

Abstract

Streptococcal toxic shock syndrome (STSS) is an illness with high mortality. To obtain clues to understanding the pathogenesis of STSS, we investigated the expression of several pathogenic factors in ten group A streptococcus (GAS) isolates from ten patients with STSS in Japan, in comparison with ten GAS isolates from children with scarlet fever. The ten scarlet fever-derived GAS isolates were equally low in lethality and anti-phagocytic activity in mice and in the production of streptolysin O (SLO), and equally high in production of superantigenic exotoxins (SAGTs) and cysteine proteinase. By comparison, the ten STSS-derived GAS isolates were heterogeneous in the expression of the above pathogenic factors, which ranged from low to high values. Most of the ten STSS-derived isolates were higher in lethality and anti-phagocytic activity and production of SLO, and lower in the production of SAGTs and cysteine proteinase than the ten scarlet fever-derived isolates. The results suggest that the lethality and anti-phagocytic activity examined in mice and SLO may be involved mainly in the development of most of the ten STSS cases. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502465     DOI: 10.1006/mpat.1999.0302

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

1.  Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice.

Authors:  B Limbago; K S McIver; V Penumalli; B Weinrick; J R Scott
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases.

Authors:  R G Kansal; A McGeer; D E Low; A Norrby-Teglund; M Kotb
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Role of streptolysin O in a mouse model of invasive group A streptococcal disease.

Authors:  B Limbago; V Penumalli; B Weinrick; J R Scott
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo.

Authors:  Michael C Fontaine; Jeong Jin Lee; Michael A Kehoe
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity.

Authors:  Paul Sumby; Adeline R Whitney; Edward A Graviss; Frank R DeLeo; James M Musser
Journal:  PLoS Pathog       Date:  2006-01-27       Impact factor: 6.823

Review 6.  Interaction of Macrophages and Cholesterol-Dependent Cytolysins: The Impact on Immune Response and Cellular Survival.

Authors:  Roshan Thapa; Sucharit Ray; Peter A Keyel
Journal:  Toxins (Basel)       Date:  2020-08-19       Impact factor: 4.546

7.  Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection.

Authors:  Murielle Baltazar; Mansoor Alsahag; Jenny Clarke; Stavros Panagiotou; Marion Pouget; William A Paxton; Georgios Pollakis; Dean Everett; Neil French; Aras Kadioglu
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.